Stockreport

Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives

Tevogen Bio Holdings Inc.  (TVGN) 
PDF Acquire cell therapy manufacturing facility with clinical and commercial capabilitiesFurther ExacTcell platform for additional clinical trials based on successful comple [Read more]